These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 9887158

  • 1. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 2. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG.
    N Engl J Med; 2001 Jul 19; 345(3):159-64. PubMed ID: 11463009
    [Abstract] [Full Text] [Related]

  • 3. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW.
    Arch Intern Med; 2005 Mar 14; 165(5):516-20. PubMed ID: 15767526
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group.
    N Engl J Med; 2002 May 23; 346(21):1616-22. PubMed ID: 12023993
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 May 23; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 6. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 7. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic bilateral mastectomy: patterns of practice.
    Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA.
    Cancer; 2002 Jul 15; 95(2):236-42. PubMed ID: 12124821
    [Abstract] [Full Text] [Related]

  • 9. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K, National Consortium for Research into Familial Breast Cancer Psychological Group.
    J Womens Health (Larchmt); 2003 Oct 15; 12(8):769-78. PubMed ID: 14588127
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
    Kaas R, Verhoef S, Wesseling J, Rookus MA, Oldenburg HS, Peeters MJ, Rutgers EJ.
    Ann Surg; 2010 Mar 15; 251(3):488-92. PubMed ID: 20134318
    [Abstract] [Full Text] [Related]

  • 11. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI.
    Cancer J Sci Am; 2000 Mar 15; 6(1):13-20. PubMed ID: 10696733
    [Abstract] [Full Text] [Related]

  • 12. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F.
    Cancer; 2004 Nov 01; 101(9):1977-86. PubMed ID: 15389473
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC, Lillquist PP, Edge SB.
    Cancer; 2009 Dec 01; 115(23):5404-12. PubMed ID: 19787635
    [Abstract] [Full Text] [Related]

  • 14. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A.
    J Plast Reconstr Aesthet Surg; 2008 Oct 01; 61(10):1177-87. PubMed ID: 17938010
    [Abstract] [Full Text] [Related]

  • 15. Is family history related to preventive health behaviors and medical management in breast cancer patients?
    Madlensky L, Flatt SW, Bardwell WA, Rock CL, Pierce JP, WHEL Study group.
    Breast Cancer Res Treat; 2005 Mar 01; 90(1):47-54. PubMed ID: 15770526
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.
    Obstet Gynecol; 2006 Sep 01; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [Abstract] [Full Text] [Related]

  • 17. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F.
    Prev Med; 1995 Jul 01; 24(4):412-9. PubMed ID: 7479633
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Timing of familial breast cancer in sisters.
    Rebora P, Czene K, Reilly M.
    J Natl Cancer Inst; 2008 May 21; 100(10):721-7. PubMed ID: 18477799
    [Abstract] [Full Text] [Related]

  • 20. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
    Isern AE, Loman N, Malina J, Olsson H, Ringberg A.
    Eur J Surg Oncol; 2008 Oct 21; 34(10):1148-54. PubMed ID: 18434071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.